NASDAQ:LYEL | Profit Breakdown | Lyell Immunopharma, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2019-12-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30$4,000.00-$47.34M-$44.76M
2026-03-31$2,000.00-$44.26M-$24.15M
2025-12-31$6,000.00-$127.64M-$140.72M
2025-09-30$15,000.00-$37.25M-$38.85M
2025-06-30$8,000.00-$47.14M-$42.68M
2025-03-31$7,000.00-$57.37M-$52.2M
2024-12-31$11,000.00-$201.15M-$191.94M
2024-09-30$34,000.00-$50.51M-$44.58M
2024-06-30$13,000.00-$51.53M-$45.81M
2024-03-31$3,000.00-$55.58M-$60.67M
2023-12-31$13,000.00-$59.51M-$52.93M
2023-09-30$25,000.00-$59.04M-$50.85M
2023-06-30$27,000.00-$65.91M-$63.89M
2023-03-31$65,000.00-$62.56M-$66.96M
2022-12-31$48.39M-$14.78M-$8.4M
2022-09-30$3,000.00-$66.44M-$70.25M
2022-06-30$35.74M-$37.26M-$36.32M
2022-03-31$553,000.00-$68.58M-$68.14M
2021-12-31$2.82M-$47.54M-$83.71M
2021-09-30$2.76M-$49.16M-$48.88M
2021-06-30$2.63M-$62.71M-$62.6M
2021-03-31$2.45M-$55.37M-$55.04M
2020-12-31$2.31M-$39.52M-$38.86M
2020-09-30$1.07M-$36.84M-$35.72M
2020-06-30$3.12M-$102.57M-$100.66M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31$36,000.00-$269.4M-$274.45M
2024-12-31$61,000.00-$358.76M-$342.99M
2023-12-31$130,000.00-$247.01M-$234.63M
2022-12-31$84.68M-$187.06M-$183.12M
2021-12-31$10.65M-$214.78M-$250.22M
2020-12-31$7.76M-$211.94M-$204.47M
2019-12-31$657,000.00-$102.09M-$129.38M